Maxcyte (MXCT) Depreciation & Amortization - Total (2024 - 2026)

Maxcyte (MXCT) has 3 years of Depreciation & Amortization - Total data on file, last reported at $1.0 million in Q1 2026.

• Depreciation & Amortization - Total for Q1 2026 came in at $1.0 million, down 5.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 million (down 1.38% YoY), and the FY2025 annual result was $4.3 million, down 0.65% from the prior year.
• Depreciation & Amortization - Total declined to $1.0 million in Q1 2026 per MXCT's latest filing, from $1.1 million in the prior quarter.
• Over five years, Depreciation & Amortization - Total peaked at $1.1 million in Q2 2025 and troughed at $1.0 million in Q1 2026.
• A 3-year average of $1.1 million and a median of $1.1 million in 2024 frame the typical range for Depreciation & Amortization - Total.
• The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization - Total gained 0.74% in 2025, then fell 5.16% in 2026.
• A 3-year view of Depreciation & Amortization - Total shows it stood at $1.1 million in 2024, then retreated by 0.19% to $1.1 million in 2025, then declined by 2.37% to $1.0 million in 2026.
• Business Quant data shows MXCT's Depreciation & Amortization - Total at $1.0 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.